Bimethyls


November 25, 2009

Health Risks of Ocella

Filed under: Uncategorized — admin @ 7:52 am

Mass tort status is being considered in the lawsuits that have been filed against the makers of the birth control tablets Yasmin or Yaz and its generic form Ocella. This is largely due to the increasing number of cases being filed across the country where victims claim stroke and other serious health problems caused by taking Yaz or Ocella. Yaz side effects extend from ischemic stroke or heart attack, to pulmonary embolism and other blood clot related injuries.

Among the other contestations impending on Yasmin, Yaz and Ocella birth control, the pills also contain drospirenone, an element not in other oral contraceptives. The British Medical Journal issued studies in August 2009 diplaying a higher risk of venous blood clots in adult females taking drospirenone as opposed to those who took other oral contraceptives. In the same month, the FDA issued an uncorrelated warning letter to Bayer Pharmaceuticals, makers of Yasmin, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and wellbeing, these research studies have been made available free on the internet.

Lesser know birth control side effects such as SVT (Supraventricular tachycardia) and organ injury or failure (Gallbladder, Pancreas, Liver, Kidney) have also been reported as a result of using Ocella, Yasmin and Yaz. With the info available on the internet, it is more essential than ever to arm yourself with knowledge before deciding if a pharaceutical is right for you. Something as ubiquitous as ‘the pill’ can cause serious damage or even kill you if you are not careful.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • OnlyWire
  • Socialize-It
  • Digg
  • del.icio.us
  • Furl
  • StumbleUpon
  • Netscape
  • YahooMyWeb
  • Reddit
  • Slashdot
  • Ma.gnolia
  • RawSugar

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.